You are here: Industry Insights > Seroquel

News List

Luye Pharma Enters Distribution Agreement with Zuellig Pharma for Seroquel and Seroquel XR in Malaysia and Brunei, Strengthening Business Presence in Asia Pacific and Improving Access to Evidence-Base prnasia
August 02, 2021
Luye Pharma Group today announced that it has entered into an agreement with Zuellig Pharma, a leading healthcare service group in Asia, under which the company grants Zuellig Pharma exclusive rights to distribute its central nervous system drugs ...
Luye Pharma and Distriphil Enter Exclusive Distribution Partnership in the Philippines with Joint Commitment to Raising Mental Health Awareness prnasia
November 27, 2020
Luye Pharma Group, an international pharmaceutical company dedicated to the R&D, manufacturing and sale of innovative medications has entered a new partnership agreement with Distribution Solutions Phils., Inc. (Distriphil), a national pharmaceutical ...
AstraZeneca Divests Rights to Seroquel, Seroquel XR in US and Canada americanpharmaceuticalreview
December 30, 2019
AstraZeneca has agreed to sell the commercial rights to Seroquel (quetiapine fumarate immediate release) and Seroquel XR (quetiapine fumarate extended release) ...
AstraZeneca closes deal with Cheplapharm for rights to Seroquel and Seroquel XR in Europe and Russia pharmaceutical-business-review
December 20, 2019
AstraZeneca has completed an agreement to divest its commercial rights to Seroquel (quetiapine fumarate immediate release) and Seroquel XR ...
Agreement with Cheplapharm for rights to Seroquel and Seroquel XR in Europe and Russia completed worldpharmanews
December 17, 2019
AstraZeneca has completed an agreement to divest its commercial rights to Seroquel (quetiapine fumarate immediate release) and Seroquel XR (quetiapine fumarate extended release) ...
Texas spanks AstraZeneca as a repeat offender in settling Seroquel, Crestor whistleblower suits fiercepharma
August 09, 2018
Add another $100 million or so to AstraZeneca’s billion-dollar tally of Seroquel legal settlements. The pharma giant has agreed to settle a Texas Medicaid fraud lawsuit that claimed it hawked the powerful antipsychotic for unapproved uses......
Luye Pharma acquires AstraZeneca's signature products biospectrumasia
May 29, 2018
A Move Aimed at Enriching the Existing CNS Portfolio and Enhancing Strategic Synergy across International Markets
AstraZeneca and Luye Pharma Group enter agreement for rights to Seroquel and Seroquel XR in the UK, China and other international markets worldpharmanews
May 11, 2018
AstraZeneca has entered into an agreement with Luye Pharma Group, Ltd. (Luye Pharma) for the sale and licence of the rights to Seroquel and Seroquel XR in the UK...
AstraZeneca continues yard-sale strategy with $538M Seroquel rights deal fiercepharma
May 09, 2018
AstraZeneca is back at it again with asset sales. The company, which has taken some flak for a series of deals to offload asset rights, inked an agreement with Luye Pharma for legacy antipsychotic Seroquel and an extended-release version...